Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Oral corticosteroids for multiple sclerosis relapse.
Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes.
External memory aids for memory problems in people with multiple sclerosis: A systematic review.
PERK-opathies: an endoplasmic reticulum stress mechanism underlying neurodegeneration.
Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
Impact of anger on the health-related quality of life of multiple sclerosis patients.
Network collapse and cognitive impairment in multiple sclerosis.
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?
Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications.
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Nanovesicle-based platform for the electrophysiological monitoring of aquaporin-4 and the real-time detection of its antibody.
Human aquaporin 4 gene polymorphisms in Chinese patients with neuromyelitis optica.
Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System.
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders.
A review on ROCK-II inhibitors: From molecular modelling to synthesis.
Magnetic resonance monitoring of lesion evolution in multiple sclerosis.
Clinical Outcomes Following Surgical Management of Coexistent Cervical Stenosis and Multiple Sclerosis: A Cohort Controlled Analysis.
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
[Alemtuzumab for relapsing-remitting multiple sclerosis : Results of two randomized controlled phase III studies.]
The utility of multimodal evoked potentials in multiple sclerosis prognostication.
Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.

Pages